Spots Global Cancer Trial Database for Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
Official Title: Phase II Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
Study ID: NCT03381352
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the efficacy and adverse events of intensity modulated radiation therapy (IMRT) concurrent with chemotherapy for anal squamous carcinoma. All enrolled anal squamous carcinoma patients are intented to receive IMRT concurrent with Capecitabine + mitomycin ± cetuximab targeted therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chinese academy of medical sciences, Beijing, Beijing, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
